Taya S, Shinoda T, Tsuboi D, Asaki J, Nagai K, Hikita T, et al
Further evidence will be necessary before we can see the complete picture, but they show promise as, at the minimum, an adjunct to current therapy, says Esposito
In addition, the systemic use of antibiotics has been documented to affect various organ systems, leading to heightened organism toxicity (Berry et al., 1995
Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W (1993) Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients
Cho PG, Jang JH, Ko S, Shin DA, Chung S, Chang MC (2023) The Effect of Evogliptin Tartrate on Controlling Inflammatory Pain
Can GLP-1 drugs be used in combination with other diabetes medications